Andrew Arno's Insider Trades & SAST Disclosures
Andrew Arno's most recent trade in 22nd Century Group Inc was a trade of 12,713 Non-Qualified Stock Option done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Andrew Arno.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
22nd Century Group Inc
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 12,713 | 12,713 | - | - | Non-Qualified Stock Option | |
|
22nd Century Group Inc
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,237 | 4,284 (0%) | 0% | 0 | Common Stock | |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 25,000 | 67,514 (0%) | 0% | 0 | Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 26 Dec 2024 | 12,500 | 81,554 (0%) | 0% | 2.1 | 26,350 | Common Stock, no par value |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 30,000 | 30,000 | - | - | Option to Purchase Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 11 Apr 2024 | 33,898 | 69,054 (0%) | 0% | 2.9 | 99,999 | Common Stock, no par value |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 25,000 | 340,105 (0%) | 0% | 0 | Common Stock | |
|
22nd Century Group Inc
|
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 05 Jan 2024 | 100,000 | 100,000 (0%) | 0% | 0.2 | 17,490 | Common Stock |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 03 Apr 2023 | 141,084 | 156,084 (0%) | 0% | 0.4 | 50,000 | Common Stock, no par value |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 03 Apr 2023 | 141,084 | 156,084 (0%) | 0% | 0.4 | 50,000 | Common Stock, no par value |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 03 Apr 2023 | 141,084 | 673,133 (1%) | 0% | 0.4 | 50,000 | Common Stock, no par value |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 25,000 | 315,105 (0%) | 0% | 0 | Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.35 per share. | 23 Dec 2022 | 250,000 | 532,049 (0%) | 0% | 0.4 | 87,875 | Common Stock, no par value |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 17 Aug 2022 | 25,000 | 287,605 (0%) | 0% | 2.4 | 58,755 | Common Stock |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 17 Aug 2022 | 7,500 | 15,000 (0%) | 0% | 0.9 | 6,750 | Common Stock, no par value |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 17 Aug 2022 | 7,500 | 15,000 (0%) | 0% | 0.9 | 6,750 | Common Stock, no par value |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 17 Aug 2022 | 5,000 | 15,000 (0%) | 0% | 2.4 | 11,757 | Common Stock |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 17 Aug 2022 | 5,000 | 15,000 (0%) | 0% | 2.4 | 11,757 | Common Stock |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 17 Aug 2022 | 5,000 | 15,000 (0%) | 0% | 2.4 | 11,757 | Common Stock |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 17 Aug 2022 | 2,500 | 290,105 (0%) | 0% | 2.2 | 5,449 | Common Stock |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 15 Aug 2022 | 115,523 | 282,049 (0%) | 0% | 1.0 | 112,057 | Common Stock, no par value |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 15 Aug 2022 | 34,477 | 166,526 (0%) | 0% | 0.9 | 32,064 | Common Stock, no par value |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 10,000 | 132,049 (0%) | 0% | 0 | Common Stock, no par value | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 122,049 (0%) | 0% | 0 | Common Stock, no par value | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 0 | - | - | Restricted Stock Units | |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 25,000 | 262,605 (0%) | 0% | 0 | Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 237,610 (0%) | 0% | 0 | Common Stock | |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 9,602 | 112,049 (0%) | 0% | - | Common Stock | |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 3.94 per share. | 10 Aug 2020 | 10,000 | 10,000 (0%) | 0% | 3.9 | 39,450 | Common Stock |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 3.95 per share. | 10 Aug 2020 | 10,000 | 212,610 (0%) | 0% | 3.9 | 39,460 | Common Stock |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 3.94 per share. | 10 Aug 2020 | 2,500 | 10,000 (0%) | 0% | 3.9 | 9,858 | Common Stock |
|
Smith Micro Software, Inc.
|
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 3.93 per share. | 10 Aug 2020 | 2,500 | 10,000 (0%) | 0% | 3.9 | 9,830 | Common Stock |
|
Oncocyte Corporation
Board Meeting |
Andrew Arno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 57,000 | 57,000 | - | - | Option to purchase common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges